Age-Dependent Directional Reversal of Total Testosterone Associations across the Phenome in NHANES 2011–2023
This study of 21,847 NHANES adults reveals that total testosterone exhibits age-dependent directional reversals across eleven diverse disease associations, demonstrating that pooled null findings often mask opposing age-specific effects and necessitating age-stratified reporting in hormone-disease research.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Hormones are the body's chemical messengers, circulating through the blood to tell organs when to grow, when to burn energy, and when to rest. Among these, testosterone is often thought of as a single, steady force that simply declines as men and women get older. For decades, scientists have tried to link the amount of this hormone in the blood to the risk of developing diseases like heart trouble, diabetes, or broken bones. The results of these studies have been frustratingly inconsistent. Sometimes, having more testosterone seemed to protect people; other times, it seemed to put them at risk. This confusion has led researchers to wonder if the hormone itself is unpredictable, or if the way we are looking at it is the problem. The prevailing idea has been that if you mix everyone together in one big group, the true relationship should eventually show up. But what if the relationship changes depending on how old you are? What if the hormone acts like a helpful neighbor in one stage of life and a different kind of neighbor in another?
A new analysis of nearly 22,000 adults from the United States suggests that the confusion comes from looking at the whole picture at once. The researchers, led by Majid Nazari at the University of New South Wales, examined data collected over more than a decade from a national health survey. They measured total testosterone levels in the blood and checked them against a wide range of health conditions, from heart disease and obesity to hearing loss and sleep problems. Instead of treating all the participants as one large group, the team looked for a specific turning point in middle age where the connection between testosterone and disease might flip. They scanned ages between 40 and 60, searching for the exact moment where the direction of the association changed.
What they found was a clear and structured pattern that had been hidden in plain sight. For eleven different health conditions, the relationship between testosterone and disease did not stay the same; it reversed direction at a specific age boundary. In many cases, a higher level of testosterone was linked to a higher risk of a disease in younger adults, but a lower risk in older adults, or vice versa. When researchers looked at the entire group without splitting them by age, these opposite effects canceled each other out, making it look like there was no connection at all. It is as if two people pulling a rope in opposite directions with equal strength make the rope appear stationary, even though both are pulling hard.
One of the most striking examples involved heart disease in men. In men under the age of 52, higher testosterone levels were associated with a higher likelihood of having coronary heart disease. However, for men older than 52, the pattern flipped: higher testosterone was linked to a lower likelihood of heart disease. When the data was mixed together, the result was a flat line, suggesting no link between the hormone and the disease. The same phenomenon appeared in women regarding conditions like hearing loss and low HDL cholesterol, and in men regarding insomnia. For instance, in women, higher testosterone was linked to a lower risk of hearing loss before age 50, but a higher risk after that age. The study identified these turning points with high statistical confidence, using a rigorous method that shuffled the data to ensure the results were not just random noise.
The researchers also looked at how severe these conditions were, not just whether people had them. They found that the reversal happened not only in the diagnosis of diseases but also in the underlying biological markers. For example, in men, higher testosterone was linked to lower levels of certain liver enzymes in younger men, but higher levels in older men. In women, the link between testosterone and insulin resistance, a precursor to diabetes, showed a similar flip. The study confirmed that these changes were not simply due to differences in body weight or fat, as the patterns held true even after accounting for body mass and waist size. Furthermore, the results remained consistent even when the researchers excluded people taking medications that directly alter hormone levels, such as testosterone therapy or drugs for prostate issues.
The findings suggest that the body's response to testosterone is not fixed but depends heavily on the stage of life. This aligns with a broader biological concept known as the "timing hypothesis," which has been observed in other areas of health, such as how hormone therapy affects heart disease risk in women. The study indicates that the reproductive system and the aging process are deeply intertwined, and that the protective or harmful effects of sex hormones shift as the body moves from its reproductive prime into later life. For men, the turning point for heart disease appeared around age 52, while for women, the shifts often occurred between ages 48 and 60, coinciding with the menopausal transition.
This work challenges the standard way hormone research is often reported. If scientists continue to pool data from young and old people together, they may miss these critical shifts and conclude that a hormone has no effect when it actually has two opposing ones. The study argues that future research must report results separately for different age groups to reveal the true nature of these relationships. By recognizing that the direction of the association changes with age, doctors and researchers can better understand why a treatment might help one group of patients while harming another. The study does not claim to have solved every mystery of hormone health, but it provides a clear map showing that the relationship between testosterone and disease is not a straight line, but a journey that changes course in midlife.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.